Razieh Avan

633 total citations
23 papers, 432 citations indexed

About

Razieh Avan is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Razieh Avan has authored 23 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Oncology. Recurrent topics in Razieh Avan's work include COVID-19 Clinical Research Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Chemotherapy-related skin toxicity (3 papers). Razieh Avan is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Chemotherapy-related skin toxicity (3 papers). Razieh Avan collaborates with scholars based in Iran, United Kingdom and Netherlands. Razieh Avan's co-authors include Amirhossein Sahebkar, Adeleh Sahebnasagh, Fatemeh Saghafi, Ebrahim Salehifar, Mohammadreza Safdari, Solomon Habtemariam, Nasim Tabrizi, Ghasem Janbabaei, Afsaneh Sadremomtaz and Abbas Alipour and has published in prestigious journals such as Phytochemistry, European Journal of Pharmacology and Current Medicinal Chemistry.

In The Last Decade

Razieh Avan

20 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Razieh Avan Iran 11 90 80 68 68 52 23 432
Vi Nguyen United States 11 36 0.4× 98 1.2× 77 1.1× 15 0.2× 37 0.7× 19 479
Tarek M. Ali Egypt 17 26 0.3× 161 2.0× 26 0.4× 34 0.5× 30 0.6× 38 607
Anella Saviano Italy 16 45 0.5× 168 2.1× 50 0.7× 22 0.3× 33 0.6× 27 450
Vahid Asghariazar Iran 13 28 0.3× 164 2.0× 75 1.1× 20 0.3× 30 0.6× 36 439
Moussa Ide Nasser China 14 48 0.5× 367 4.6× 68 1.0× 28 0.4× 42 0.8× 31 716
Jushuang Li China 6 43 0.5× 183 2.3× 101 1.5× 19 0.3× 39 0.8× 7 490
Renbin Huang China 13 47 0.5× 146 1.8× 175 2.6× 17 0.3× 46 0.9× 32 590
Manal Fardoun Lebanon 13 16 0.2× 168 2.1× 49 0.7× 23 0.3× 25 0.5× 23 522
Xiaoke Wu China 11 42 0.5× 132 1.6× 112 1.6× 20 0.3× 59 1.1× 40 583
Zhe Meng China 12 49 0.5× 216 2.7× 65 1.0× 73 1.1× 35 0.7× 24 635

Countries citing papers authored by Razieh Avan

Since Specialization
Citations

This map shows the geographic impact of Razieh Avan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Razieh Avan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Razieh Avan more than expected).

Fields of papers citing papers by Razieh Avan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Razieh Avan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Razieh Avan. The network helps show where Razieh Avan may publish in the future.

Co-authorship network of co-authors of Razieh Avan

This figure shows the co-authorship network connecting the top 25 collaborators of Razieh Avan. A scholar is included among the top collaborators of Razieh Avan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Razieh Avan. Razieh Avan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghafari, Shokouh, et al.. (2024). Evaluation of the effect of melatonin on patients with COVID-19 admitted to ICU: A double-blind randomized clinical trial. Vacunas. 26(1). 100377–100377. 1 indexed citations
2.
Sahebnasagh, Adeleh, et al.. (2022). Neurohormetic phytochemicals in the pathogenesis of neurodegenerative diseases. Immunity & Ageing. 19(1). 36–36. 24 indexed citations
3.
Avan, Razieh, Afrooz Mazidimoradi, & Hamid Salehiniya. (2022). Effect of magnesium on severity and mortality of COVID–19 patients. Journal of Acute Disease. 11(4). 120–126.
4.
5.
Avan, Razieh, Jafar Âkbari, Ghasem Janbabaei, et al.. (2021). Malus domestica reduces chemotherapy-induced nausea and vomiting. Journal of Research in Medical Sciences. 26(1). 72–72. 3 indexed citations
6.
Sahebnasagh, Adeleh, Javad Hashemi, Fatemeh Saghafi, et al.. (2021). Aromatic hydrocarbon receptors in mitochondrial biogenesis and function. Mitochondrion. 61. 85–101. 13 indexed citations
7.
Sahebnasagh, Adeleh, et al.. (2021). L-carnitine: Searching for New Therapeutic Strategy for Sepsis Management. Current Medicinal Chemistry. 29(18). 3300–3323. 4 indexed citations
8.
Avan, Razieh, et al.. (2021). Therapeutic Effects of Punica granatum (Pomegranate): An Updated Review of Clinical Trials. Journal of Nutrition and Metabolism. 2021. 1–22. 59 indexed citations
9.
Avan, Razieh, Adeleh Sahebnasagh, Javad Hashemi, et al.. (2021). Update on Statin Treatment in Patients with Neuropsychiatric Disorders. Life. 11(12). 1365–1365. 21 indexed citations
10.
Sahebnasagh, Adeleh, Razieh Avan, Fatemeh Saghafi, et al.. (2020). Pharmacological treatments of COVID-19. Pharmacological Reports. 72(6). 1446–1478. 38 indexed citations
11.
Salehifar, Ebrahim, et al.. (2020). Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial. Clinical Drug Investigation. 40(3). 249–257. 47 indexed citations
12.
Sahebnasagh, Adeleh, Fatemeh Saghafi, Mohammadreza Safdari, et al.. (2020). Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID‐19. Journal of Clinical Pharmacy and Therapeutics. 45(6). 1515–1519. 82 indexed citations
13.
Sahebnasagh, Adeleh, Fatemeh Saghafi, Razieh Avan, et al.. (2020). The prophylaxis and treatment potential of supplements for COVID-19. European Journal of Pharmacology. 887. 173530–173530. 35 indexed citations
14.
Avan, Razieh, et al.. (2020). Iranian Salvia species: A phytochemical and pharmacological update. Phytochemistry. 183. 112619–112619. 38 indexed citations
15.
Salehifar, Ebrahim, Ghasem Janbabaei, Abbas Alipour, Nasim Tabrizi, & Razieh Avan. (2020). Taxane-induced peripheral neuropathy and quality of life in breast cancer patients. Journal of Oncology Pharmacy Practice. 26(6). 1421–1428. 12 indexed citations
16.
Salehifar, Ebrahim, et al.. (2018). The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial. Journal of Research in Medical Sciences. 23(1). 52–52. 36 indexed citations
17.
Ala, Shahram, et al.. (2017). Prevalence and Management of Stress Hyperglycemia in Critical Care Unit. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences. 26(144). 1–11.
18.
Salehifar, Ebrahim, et al.. (2017). Pharmacokinetic Parameters and Over-Responsiveness of Iranian Population to Propranolol. Advanced Pharmaceutical Bulletin. 7(2). 195–202. 2 indexed citations
19.
Salehifar, Ebrahim, et al.. (2016). Evluation of Preventing Regimens Used for Chemotherapy Induced Nausea and Vomiting. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences. 25(133). 227–235. 1 indexed citations
20.
Salehifar, Ebrahim, et al.. (2015). EFFICACY OF ORAL DEFERASIROX BY TWICE-DAILY DOSING IN PATIENTS WITH TRANSFUSION-DEPENDENT BETA THALASSEMIA. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences. 25(129). 1–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vi Nguyen Breakdown of academic impact, for papers by Tarek M. Ali Breakdown of academic impact, for papers by Anella Saviano Breakdown of academic impact, for papers by Vahid Asghariazar Breakdown of academic impact, for papers by Moussa Ide Nasser Breakdown of academic impact, for papers by Jushuang Li Breakdown of academic impact, for papers by Renbin Huang Breakdown of academic impact, for papers by Manal Fardoun Breakdown of academic impact, for papers by Xiaoke Wu Breakdown of academic impact, for papers by Zhe Meng
Rankless by CCL
2026